WHO ICTRP trial
Randomized Controlled Trial of Rabeprazol Versus Placebo Administration in the…
JPRN-UMIN000003913 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000003913 |
|---|---|
| Public title | Randomized Controlled Trial of Rabeprazol Versus Placebo Administration in the Prevention of Esophageal Variceal Bleeding After Esophageal Variceal Ligation |
| Scientific title | Randomized Controlled Trial of Rabeprazol Versus Placebo Administration in the Prevention of Esophageal Variceal Bleeding After Esophageal Variceal Ligation - POST-EVL Study |
| Primary sponsor | Post-EVL Study Office |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | Patients after esophageal variceal ligation (EVL) |
| Interventions | Rabeprazol Placebo |
| Registration date | Jul 15, 2010 |
| Target size | 44 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: